eflornithine has been researched along with amprenavir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Buckner, FS; Fan, E; Gillespie, JR; Hol, WG; Kim, JE; Koh, CY; Laydbak, JU; Ranade, RM; Shibata, S; Verlinde, CL; Zucker, FH | 1 |
2 other study(ies) available for eflornithine and amprenavir
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Urea-based inhibitors of Trypanosoma brucei methionyl-tRNA synthetase: selectivity and in vivo characterization.
Topics: Administration, Oral; Aminoquinolines; Animals; Biological Availability; Brain; Cell Line; Cell Membrane Permeability; Enzyme Inhibitors; Female; Humans; Methionine-tRNA Ligase; Mice; Models, Molecular; Protein Conformation; Substrate Specificity; Trypanosoma brucei brucei; Urea | 2012 |